Latest News

Cannabis constituent has no effect on multiple sclerosis progression, study shows

The first large non-commercial clinical study to investigate whether the main active constituent of cannabis (tetrahydrocannabinol or THC) is effective in slowing the course of progressive multiple sclerosis, shows that there is no evidence to suggest this; although benefits were noted for those at the lower end of the disability scale.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Family criticizing your weight? You might add more pounds

  • Early exposure to antidepressants affects adult anxiety, serotonin transmission

  • Cocaine, amphetamine users more likely to take their own lives

  • New technology advances eye tracking as biomarker for brain function, recovery from brain injury

  • Tracking the eyes: The keys to consumers' plant preferences

  • Naming people, objects in baby's first year may offer learning benefits years later

  • Meth users face substantially higher risk for getting Parkinson's disease

  • First real-time mri-guided brain surgery for Parkinson's in southern California

  • How, where the brain converts external inputs into behavioral responses

  • Teen contraband smokers more likely to use illicit drugs: Study

  •